PT1482967E - Composições farmacêuticas e cosmética compreendendo plgf-1 - Google Patents

Composições farmacêuticas e cosmética compreendendo plgf-1 Download PDF

Info

Publication number
PT1482967E
PT1482967E PT37126521T PT03712652T PT1482967E PT 1482967 E PT1482967 E PT 1482967E PT 37126521 T PT37126521 T PT 37126521T PT 03712652 T PT03712652 T PT 03712652T PT 1482967 E PT1482967 E PT 1482967E
Authority
PT
Portugal
Prior art keywords
plgf
scleroderma
pglf
type
use according
Prior art date
Application number
PT37126521T
Other languages
English (en)
Portuguese (pt)
Inventor
Giuseppe Salvia
Ettore Conti
Domenico Maglione
Mauro Battisti
Marina Tucci
Original Assignee
Geymonat Spa
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=11456138&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=PT1482967(E) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Geymonat Spa filed Critical Geymonat Spa
Publication of PT1482967E publication Critical patent/PT1482967E/pt

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
    • A61Q7/00—Preparations for affecting hair growth
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • A61K38/18—Growth factors; Growth regulators
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • A61K38/18—Growth factors; Growth regulators
    • A61K38/1858—Platelet-derived growth factor [PDGF]
    • A61K38/1866—Vascular endothelial growth factor [VEGF]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00—Cosmetics or similar toiletry preparations
    • A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
    • A61K8/64—Proteins; Peptides; Derivatives or degradation products thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A61P17/02—Drugs for dermatological disorders for treating wounds, ulcers, burns, scars, keloids, or the like
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A61P17/14—Drugs for dermatological disorders for baldness or alopecia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00—Drugs for skeletal disorders
    • A61P19/02—Drugs for skeletal disorders for joint disorders, e.g. arthritis, arthrosis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00—Drugs for skeletal disorders
    • A61P19/04—Drugs for skeletal disorders for non-specific disorders of the connective tissue
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P21/00—Drugs for disorders of the muscular or neuromuscular system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P5/00—Drugs for disorders of the endocrine system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/14—Vasoprotectives; Antihaemorrhoidals; Drugs for varicose therapy; Capillary stabilisers
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
    • A61Q19/00—Preparations for care of the skin
    • A61Q19/08—Anti-ageing preparations

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • General Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Dermatology (AREA)
  • Epidemiology (AREA)
  • Immunology (AREA)
  • Physical Education & Sports Medicine (AREA)
  • Vascular Medicine (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Zoology (AREA)
  • Gerontology & Geriatric Medicine (AREA)
  • Orthopedic Medicine & Surgery (AREA)
  • Birds (AREA)
  • Diabetes (AREA)
  • Biomedical Technology (AREA)
  • Neurology (AREA)
  • Endocrinology (AREA)
  • Rheumatology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Cardiology (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Cosmetics (AREA)
  • Medicinal Preparation (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
PT37126521T 2002-03-05 2003-03-05 Composições farmacêuticas e cosmética compreendendo plgf-1 PT1482967E (pt)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
IT2002RM000119A ITRM20020119A1 (it) 2002-03-05 2002-03-05 Composizioni contenenti plgf ad uso farmaceutico e cosmetico.

Publications (1)

Publication Number Publication Date
PT1482967E true PT1482967E (pt) 2013-08-27

Family

ID=11456138

Family Applications (1)

Application Number Title Priority Date Filing Date
PT37126521T PT1482967E (pt) 2002-03-05 2003-03-05 Composições farmacêuticas e cosmética compreendendo plgf-1

Country Status (21)

Country Link
US (1) US7364722B2 (zh)
EP (1) EP1482967B1 (zh)
JP (2) JP5010093B2 (zh)
KR (1) KR100988656B1 (zh)
CN (1) CN100467058C (zh)
AU (1) AU2003217464B2 (zh)
BR (1) BR0308040A (zh)
CA (1) CA2477075C (zh)
CY (1) CY1114209T1 (zh)
DK (1) DK1482967T3 (zh)
ES (1) ES2424827T3 (zh)
HK (1) HK1078469A1 (zh)
HR (1) HRP20040914A2 (zh)
IT (1) ITRM20020119A1 (zh)
MX (1) MXPA04008486A (zh)
PL (1) PL371788A1 (zh)
PT (1) PT1482967E (zh)
RU (1) RU2292906C2 (zh)
SI (1) SI1482967T1 (zh)
WO (1) WO2003074075A1 (zh)
ZA (1) ZA200407707B (zh)

Families Citing this family (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2872040B1 (fr) * 2004-06-23 2006-09-22 Centre Nat Rech Scient Cnrse Utilisation cosmetique d'au moins un tetrapeptide naturel ac-n-ser-asp-lys-pro- ou un de ses analogues en tant qu'agent antivieillissement et restructurant de la peau
US8057458B2 (en) * 2006-10-30 2011-11-15 Warsaw Orthopedic, Inc. Method for treating facet pain
US20110294734A1 (en) * 2009-02-05 2011-12-01 Digna Biotech, S.L. Pharmaceutical compositions comprising tgf-beta 1 inhibitor peptides
US8741850B2 (en) 2009-07-24 2014-06-03 Advanced Accelerator Applications S.A. Compounds modulators of VEGF activity and uses thereof
EP2948164B1 (en) 2013-01-28 2019-04-10 Shire Human Genetic Therapies, Inc. Placenta growth factor in treating duchenne muscular dystrophy
EP3094336A4 (en) 2014-01-17 2018-02-14 MIMEDX Group Inc. Method for inducing angiogenesis

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
IT1242149B (it) 1990-09-27 1994-02-16 Consiglio Nazionale Ricerche Sequenza di nucleotidi codificante per una proteina umana con proprieta' regolative dell'angiogenesi
CA2229479C (en) * 1995-08-15 2010-03-30 Connective Therapeutics, Inc. Method of promoting angiogenesis
JP2003517265A (ja) * 1997-12-24 2003-05-27 ルードヴィッヒ インスティテュート フォー キャンサー リサーチ 血管内皮増殖因子ｄを発現する発現ベクターおよび細胞系、およびメラノーマを治療する方法
WO2001000792A1 (en) * 1999-06-29 2001-01-04 Marchosky J Alexander Compositions and methods for forming and strengthening bone
WO2001057181A2 (en) * 2000-02-04 2001-08-09 Carmeliet, Peter Use of vascular endothelial growth factor, placenta growth factor or both for preventing or treating ischemic diseases or stroke
JP2004500409A (ja) * 2000-03-31 2004-01-08 ザ　ジェネラル　ホスピタル　コーポレーション 毛の成長を調節する方法

Also Published As

Publication number Publication date
WO2003074075A1 (en) 2003-09-12
CN1638793A (zh) 2005-07-13
JP2010116405A (ja) 2010-05-27
CN100467058C (zh) 2009-03-11
JP2005519101A (ja) 2005-06-30
US20050075288A1 (en) 2005-04-07
AU2003217464A1 (en) 2003-09-16
EP1482967B1 (en) 2013-05-15
SI1482967T1 (sl) 2013-10-30
CA2477075C (en) 2013-08-06
KR100988656B1 (ko) 2010-10-18
BR0308040A (pt) 2004-12-14
ITRM20020119A1 (it) 2003-09-05
HK1078469A1 (en) 2006-03-17
RU2004129586A (ru) 2005-06-10
ITRM20020119A0 (it) 2002-03-05
JP5144690B2 (ja) 2013-02-13
AU2003217464B2 (en) 2007-08-30
JP5010093B2 (ja) 2012-08-29
CY1114209T1 (el) 2016-08-31
ES2424827T3 (es) 2013-10-08
ZA200407707B (en) 2005-07-27
MXPA04008486A (es) 2005-04-19
US7364722B2 (en) 2008-04-29
RU2292906C2 (ru) 2007-02-10
EP1482967A1 (en) 2004-12-08
DK1482967T3 (da) 2013-08-26
PL371788A1 (en) 2005-06-27
CA2477075A1 (en) 2003-09-12
HRP20040914A2 (en) 2004-12-31
US20050239698A2 (en) 2005-10-27
KR20040111379A (ko) 2004-12-31

Similar Documents

Publication Publication Date Title
AU2003255290B2 (en) Use of erythropoietin
JP5792057B2 (ja) 創傷治癒における瘢痕形成を低減するための組成物および方法
BR112012001491B1 (pt) Preparação terapêutica para tratar dermatite e uso de uma preparação terapêutica
JP7193662B2 (ja) ペプチド成分の皮膚再生および治癒混合物とその使用
US8685391B2 (en) Skin care compositions
JP5144690B2 (ja) Ｐｌｇｆ−１を含む医薬品及び化粧品組成物
JP2010116405A6 (ja) Ｐｌｇｆ−１を含む医薬品及び化粧品組成物
JP3098544B2 (ja) サイトカイン活性増強剤およびサイトカインの働きが低下した疾病の治療剤
CA2718296C (en) Agent for treating skin aging and scars
JP4096115B2 (ja) 皮膚創傷治癒促進剤
KR20230097841A (ko) EGF(Epidermal Growth Factor)를 유효성분으로하는 탈모 방지 및 발모 촉진용 조성물
KR20200062071A (ko) 지방 생성을 자극하는 펩타이드, 조성 및 방법
JP2006063033A (ja) 細胞移動促進活性ポリペプチドを含有する組成物
JP2000351711A (ja) 化粧料
JPH03106822A (ja) 皮膚創傷・皮膚疾患治療用注射剤